| P50 | author | Lara Magro | Q57717824 |
| P2093 | author name string | A Conforti | |
| | R Leone | |
| | U Moretti | |
| | E Visonà | |
| | F Del Zotti | |
| | D Massignani | |
| | I Meneghelli | |
| | M L Iorio | |
| P2860 | cites work | Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration | Q71761990 |
| | The effect of digoxin on mortality and morbidity in patients with heart failure | Q73080377 |
| | Potential drug-drug interactions in the medication of medical patients at hospital discharge | Q73121388 |
| | Drug interaction management | Q73611772 |
| | Clinical benefits of low serum digoxin concentrations in heart failure | Q77772125 |
| | Drug-drug interactions in the elderly | Q78422796 |
| | Improving recognition of drug interactions: benefits and barriers to using automated drug alerts | Q78591485 |
| | Exposure to potential drug interactions in primary health care | Q79128884 |
| | Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety | Q79439832 |
| | Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital | Q79505554 |
| | Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant | Q28185473 |
| | Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy | Q28342130 |
| | Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases | Q33815762 |
| | Comparative tolerability of the HMG-CoA reductase inhibitors | Q34045770 |
| | Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin | Q34049823 |
| | Digoxin | Q34128151 |
| | Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland | Q34306841 |
| | Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial | Q34474439 |
| | Hospital admissions resulting from preventable adverse drug reactions | Q34796945 |
| | Comparative assessment of four drug interaction compendia | Q36024425 |
| | ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G | Q36259700 |
| | Clinical drug interactions in outpatients of a university hospital in Thailand | Q36335035 |
| | Detection of potential drug interactions - a model for a national pharmacy register | Q36560351 |
| | Hospitalisations and emergency department visits due to drug-drug interactions: a literature review | Q36677190 |
| | The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events | Q36737045 |
| | Potential Drug Interactions in an Ambulatory Geriatric Population | Q37071042 |
| | Detecting drug interactions: a review of the literature. | Q37996568 |
| | Life-threatening digitalis intoxication with and without additional diuretic treatment (author's transl) | Q39510528 |
| | Part I Digitalis glycosides: Mechanisms and manifestations of toxicity | Q40176093 |
| | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450 | Q40284316 |
| | Cardiac glycosides. Drug interactions of clinical significance | Q40536197 |
| | Drug interactions with azithromycin and the macrolides: an overview | Q41119734 |
| | Medication prescribing on a university medical service-the incidence of drug combinations with potential adverse interactions | Q41711807 |
| | Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases | Q43593878 |
| | Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. | Q44699697 |
| | Statin-macrolide interaction risk: a population-based study throughout a general practice database. | Q46619247 |
| | Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. | Q50561729 |
| | Potential drug--drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. | Q51040269 |
| | Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors | Q56638585 |
| | A medication database - a tool for detecting drug interactions in hospital | Q60682693 |
| | Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations | Q67749446 |
| | Frequency of hypomagnesemia in hospitalized patients receiving digitalis | Q70083035 |
| | The influence of verapamil on serum digoxin concentration | Q70333541 |
| | Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation | Q70333588 |
| | Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients | Q71260888 |
| | Amiodarone-digoxin interaction. Clinical and experimental observations | Q71389574 |
| | Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications | Q71395157 |
| | Interaction between digoxin and calcium antagonists and antiarrhythmic drugs | Q71682856 |
| P433 | issue | 3 | |
| P921 | main subject | Italy | Q38 |
| | drug interaction | Q718753 |
| P304 | page(s) | 303-309 | |
| P577 | publication date | 2007-11-09 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Identification of severe potential drug-drug interactions using an Italian general-practitioner database | |
| P478 | volume | 64 | |